These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12198818)

  • 1. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
    Apfel SC
    Int Rev Neurobiol; 2002; 50():393-413. PubMed ID: 12198818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors in the therapy of diabetic neuropathy.
    Apfel SC
    Am J Med; 1999 Aug; 107(2B):34S-42S. PubMed ID: 10484043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
    Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
    JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factors and their receptors in human sensory neuropathies.
    Anand P
    Prog Brain Res; 2004; 146():477-92. PubMed ID: 14699981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic factors and diabetic peripheral neuropathy.
    Apfel SC
    Eur Neurol; 1999; 41 Suppl 1():27-34. PubMed ID: 10023126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
    Elias KA; Cronin MJ; Stewart TA; Carlsen RC
    Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy.
    Freeman R
    Eur Neurol; 1999; 41 Suppl 1():20-6. PubMed ID: 10023125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological actions of nerve growth factor in the peripheral nervous system.
    Rask CA
    Eur Neurol; 1999; 41 Suppl 1():14-9. PubMed ID: 10023124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nerve growth factor (NGF) in treatment of diabetic polyneuropathy. One hope less?].
    Quasthoff S; Hartung HP
    Nervenarzt; 2001 Jun; 72(6):456-9. PubMed ID: 11433707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
    Rogers BC
    Neurotoxicology; 1996; 17(3-4):865-70. PubMed ID: 9086510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.
    Koliatsos VE; Applegate MD; Knüsel B; Junard EO; Burton LE; Mobley WC; Hefti FF; Price DL
    Exp Neurol; 1991 May; 112(2):161-73. PubMed ID: 2037030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors.
    Tomlinson DR; Fernyhough P; Diemel LT
    Diabetes; 1997 Sep; 46 Suppl 2():S43-9. PubMed ID: 9285498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic factors in the treatment of peripheral neuropathy.
    Apfel SC; Kessler JA
    Ciba Found Symp; 1996; 196():98-108; discussion 108-12. PubMed ID: 8866130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor (NGF) may hold promise in treatment of peripheral neuropathy.
    AIDS Patient Care STDS; 1997 Jun; 11(3):197. PubMed ID: 11361801
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug shows promise for painful sensory neuropathy.
    AIDS Alert; 1998 Dec; 13(12):138-40. PubMed ID: 11366061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endogenous nerve growth factor in human diabetic neuropathy.
    Anand P; Terenghi G; Warner G; Kopelman P; Williams-Chestnut RE; Sinicropi DV
    Nat Med; 1996 Jun; 2(6):703-7. PubMed ID: 8640566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
    Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
    Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors as therapeutics for diabetic neuropathy.
    Calcutt NA; Jolivalt CG; Fernyhough P
    Curr Drug Targets; 2008 Jan; 9(1):47-59. PubMed ID: 18220712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic factors in the therapy of peripheral neuropathy.
    Apfel SC; Kessler JA
    Baillieres Clin Neurol; 1995 Nov; 4(3):593-606. PubMed ID: 8599726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.